Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

NCT03574428 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: GNbAC1
OTHER: GNbAC1 Placebo

Sponsor

GeNeuro Australia PTY Ltd